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baseline ISO:O.OO2 0.004 0.008 0016
Peak LV dP/dt ImmHg/sec) (n ~ 7)
control 2029 ± 136 2586 ± 192 2820 ± 200 3309 ± 255 4120 ± 419'
lowL-NAME 2171 ± 149 2566 ± 176 2894 ± 206 3214 ± 223 3707 ± 250*
high L-NAME 2114±166 2326 ± 193 2560 ± 152 3014 ± 140 3354 ± 171'
Wall thickenin9 (%) In ~ 2)
control 22 ± 7 25 ± 6 29 ± 5 33 ± 7 35 ± 9
low L-NAME 25 ± 11 25 ± 15 28 ± 19 31 ± 18 36 ± 21
high L-NAME 28 ± 17 25 ± 15 25 ± 15 31 ± 19 34 ± 15
LCX blood flow Iml/minKn = 7)
control 33 ± 6 48 ± 7 52 ± 6 61 ± 8 70 ± 9'
low L-NAME 36 ± 7 41 ± 8 44±9 47 ± 8 52 ± 9'
high L-NAME 33 ± 7 36 ± 8 38 ± 7 40 ± 7 48 ± 8'
mean ± SEM; 'p < 0.05
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This study was undertaken to test whether a brief period of ischemia affects
the coronary pressure-flow relationship during reduction of coronary perfu-
sion pressure ICPP). The left anterior descending coronary artery was can-
nulated and perfused with blood from the left carotid artery in 40 open-chest
dogs. Coronary blood flow (CBF) was measured during intracoronary admin-
istrations of papaverine and adenosine. Coronary pressure-flow relationship
was assessed during transient reduction of CPP from 100 to 30 mmHg with
10 mmHg intervals. Coronary hyperemic flow due to adenosine and papaver-
ine was attenuated at 30 min of reperfusion following 10 and 15 min of is-
chemia. In the group of transient 10 min ischemia, both fractional shortening
(FS} and CBF returned to the pre-ischemic values at 30 and 60 min of reper-
fusion, however, marked decreases in CBF (35 ± 5 vs 56 ± 4 ml/100 g/ml
at CPP ~ 60 mmHg, p < 0.01) during graded reductions in CPP were ob-
served. Furthermore, both FS (6 ± 1 vs 14 ± 1% at CPP = 60 mmHg. p <
001) and lactate extraction ratio (-41 ± 15 vs 1 ± 6% at CPP = 60 mmHg,
p < 0.05) were decreased. The endocardial vs. epicardial flow ratio was re-
duced relative to the control condition. The downward-shift of the coronary
perfusion pressure-flow relationship and the deterioration of myocardial con-
tractile and metabolic function during reduction of CPP were restored at 60
min of reperfusion. In contrast, in the group of transient 15 min ischemia, al-
though both baseline FS and coronary hyperemic flow due to adenosine and
papaverine remained to be at 30 and 60 min of reperfusion, the coronary
perfusion pressure-flow relationship was not shifted.
Conclusion: Transient brief period of ischemia can reversibly affect the
coronary pressure-flow relationship due to the reduced capability of vascular
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Evidence for Downward-Shift of Coronary
Pressure-Flow Relationship Following a Brief Period
of Ischemia in Dogs
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Inhibition of Nitric Oxide Synthesis does not Increase
Cardiac Contractile Response but Reduces Coronary
Blood Flow Response to p-Adrenergic Stimulation in
Normal Dogs
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Thus, inhibition of NO synthesis by L-NAME did not change baseline con-
tractility nor did it increase its response to ISO. It also did not alter base-
line blood flow. but reduced significantly its response to ISO. These data
strongly suggest that the NO system in the normal myocardium does not
modulate contractility, but NO formation in the vasculature contributes to
the {I-adrenergic coronary vasodilation.
Although the induction of nitric oxide (NO) synthesis has been implicated
as a cause of cytokine-induced depression of cardiac tl-adrenergic respon-
siveness. whether the NO system constitutively present in the normal my-
ocardium plays a role in its physiologic response to tl-adrenergic stimula-
tion in vivo remains controversial. Accordingly, we examined the effects of
low and high doses of NW-nitro-L-arginine methyl ester (L-NAME)(10 and
100 jLg/kg/min for 10 min), an NO synthase inhibitor, administered into left
circumflex coronary artery (LCX) on responses of peak left ventricular (LV)
dP/dt, regional wall thickening in LCX region and LCX blood flow to graded
intracoronary (IC) doses of isoproterenol (ISO:0.002 to 0.016 jLg/kg/min) in
7 anesthetized dogs. IC L-NAME was associated with dose-related reduc-
tions in IC acetylcholine-induced coronary vasodilation. Effects of L-NAME
on ISO-induced changes are shown:
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Nitric oxide (NOI is reported to attenuate myocardial contraction, raising
the possibility that endogenous NO decreases the inotropic response of is-
chemic myocardium. In 42 dogs, the left anterior descending coronary artery
was perfused with blood from the left carotid artery. During reduction of per-
fusion pressure (1 03 ± 6 to 53 ± 4 mmHg) so that coronary blood flow (CBF)
decreases to 60% of the control, fractional shortening (FS) of the perfused
area decreased from 23.3 ± 3.3 to 8.4 ± 1.3%. Intravenous infusions of iso-
proterenol (ISO, 75 and 150 ng/kg/min) increased FS to 15.9 ± 33 and 22.5 ±
2.5%, respectively. An infusion of L-NAME, an inhibitor of NO synthase, did
not alter FS in the non-ischemic condition (24.5 ± 2.1 %). However, changes
in FS due to reduction of C8F to 60% (FS:14.3 ± 1.3%). and intravenous
infusions of ISO during coronary hypoperfusion (FS:23.3 ± 3.3 and 32.3 ±
2.8%) were augmented in the L-NAME group compared with the untreated
group. Lactate extraction ratio (-4.1 ± 2.2 vs -15.6 ± 4.2%), and pH in the
coronary venous blood (7.32 ± 0.03 vs 7.27 ± 0.03) in the L-NAME group
were lower than the untreated group during coronary hypoperfusion. Fur-
thermore, L-arginine restored metabolic dysfunction due to L-NAME in the
ischemic myocardium. These results indicate that endogenous NO atten-
uates myocardial contractile function in the ischemic heart and improves
myocardial metabolic function. NO and NO donors such as nitrates in the
ischemic heart disease may play an importrant role for myocardial energy-
sparing effect as well as coronary vasodilation.
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Endogenous Nitric Oxide Attenuates Myocardial
Inotropic Responses in Ischemic Myocardium of the
Canine Heart
Myocardial bradykinin (BK) levels increase during ischemia. BK modulates
cardiac efferent nerves and affects cardiovascular hemostasis possibly via
BK receptors (B, or B2). We examined the effects of BK on the end-systolic
LV pressure-volume relation (ESPVR; conductance catheter method) and
blood flow (BF; electromagnetic flow probe) in 6 open-chest, instrumented
dogs. BK (0.01-1.0 nMlkg) was injected into the circumflex artery while LV
pressure-volume loops and BF were continuously monitored without and
with BK B2-receptor blockade with HOE-140 (HOE; 4.5 nM/kg; i.v.). At base-
line before HOE, LV systolic pressure, stroke volume, end-systolic volume,
the slope of the ESPVR (Ees ), dP/dtmax and BF were 104 ± 10 mmHg, 14
± 3 mL, 24 ± 4 mL, 2.9 ± 1.4 mmHg/mL, 1440 ± 62 mmHg/sec, and 33
± 12 mL/min, respectively. With intracoronary BK, Ees increased in a dose-
dependent manner (6.9 ± 2.4 mmHg/mL at 1.0 nM/kg, p :::: 0.051: BF was
higher than baseline despite lower LV pressure. After HOE, LV systolic pres-
sure increased (p :::: 0.01), stroke volume decreased (P :::: 0.011 and BF was un-
changed. HOE blocked the dose-dependent BK-mediated hypotension and
coronary vasodilatation but had no effect on peak reactive hyperemia fol-
lowing a 20 sec coronary occlusion (120 ± 47 vs 113 ± 41 mL/min; p =
NS); BF repayment time decreased significantly (47 ± 4 vs 39 ± 5 sec).
Conclusions: 1) BK augments LV contractility, 2) HOE blocks BK-mediated
increases in LV contractility, and 3) HOE does not affect peak reactive hyper-
emia but reduces repayment time. Thus, BK lowers LV pressure and volume
but increases BF secondary to augmented LV contractility. These effects may
be receptor-mediated since they were significantly attenuated after BK 82-
receptor blockade.
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